United States Infusion Systems Market Outlook to 2033 - Infusion Pumps and Infusion Pump Disposables

1.1 List of Tables
1.2 List of Figures

2.1 What Is This Report About?
2.2 Infusion Systems Market Segmentation
2.3 Definitions of Markets Covered in the Report

3.1 Infusion Systems Market, United States, Revenue ($m), 2018-2033
3.1.1 Infusion Pump Disposables Market, United States, Revenue ($m), by Segment, 2018-2033
3.1.2 Infusion Pumps Market, United States, Revenue ($m), by Segment, 2018-2033
3.2 Infusion Systems Market, United States, Volume (Units), 2018-2033
3.2.1 Infusion Pump Disposables Market, United States, Volume (Units), by Segment, 2018-2033
3.2.2 Infusion Pumps Market, United States, Volume (Units), by Segment, 2018-2033
3.3 Infusion Systems Market, United States, Average Price ($) , 2018-2033
3.4 Infusion Systems Market, United States, Distribution Share by Revenue ($m), 2023
3.5 Infusion Systems Market, United States, Company Share by Revenue ($m), 2023

4.1 B. Braun Melsungen AG
4.1.1 Company Overview
4.2 ICU Medical Inc
4.2.1 Company Overview
4.3 Baxter International Inc
4.3.1 Company Overview
4.4 Becton Dickinson and Co
4.4.1 Company Overview

6.1 Acquisition
6.1.1 ANI Pharma to Acquire Alimera Sciences for Approximately USD381 Million
6.2 Debt Offerings
6.2.1 Cardinal Health Raises USD650 Million in Public Offering of 5.125% Notes Due 2029
6.2.2 Cardinal Health Raises USD500 Million in Public Offering of 5.45% Notes Due 2034
6.3 Equity Offerings
6.3.1 TriSalus Life Sciences' Selling Shareholders to Raise USD0.77 Million in Secondary Offering of Shares
6.3.2 Trisalus Life Sciences Raises USD30 Million in Private Placement of Shares
6.4 Partnerships
6.4.1 3M to Enter into Co Development Agreement With HD Korea Shipbuilding & Offshore Engineering (KSOE)
6.4.2 KORU Medical Enters into Co-Development Agreement with Biopharmaceutical Company

7.1 Corporate Communications
7.1.1 Aug 01, 2024: 3M Names Anurag Maheshwari as Executive Vice President and Chief Financial Officer
7.1.2 Jul 10, 2024: 3M Announces Departure of Chief Financial Officer
7.1.3 Mar 12, 2024: 3M Announces New Leadership Appointments
7.1.4 Feb 28, 2024: Bob Azelby to Join Cardinal Health Board of Directors
7.1.5 Nov 09, 2023: 3M Announces Leadership Changes
7.1.6 Nov 07, 2023: Tom Sweet Elected to 3M Board of Directors
7.1.7 Aug 22, 2023: Bryan Hanson Named CEO of 3M's Health Care Business Group
7.2 Financial Announcements
7.2.1 Aug 01, 2024: TriSalus Life Sciences to Host Second Quarter 2024 Financial Results Conference Call
7.2.2 Jul 26, 2024: 3M Delivers Strong Second-Quarter Results; Company Updates Full-Year 2024 Earnings Guidance
7.2.3 Jul 25, 2024: IRADIMED to Hold 2024 Second Quarter Financial Results Conference Call on August 1st
7.2.4 May 02, 2024: IRadimed Announces First Quarter of 2024 Financial Results and the Declaration of its Regular Quarterly Cash Dividend of $0.15 Per Share
7.2.5 Apr 30, 2024: 3M First-Quarter Results Driven by Strong Operational Performance; Company Initiates Full-Year 2024 Guidance Reflecting Completion of Solventum Spin
7.2.6 Jan 23, 2024: 3M Delivers Strong Fourth-Quarter Results; Improves Operational Performance and Exceeds Earnings and Cash Flow Expectations
7.2.7 Jan 04, 2024: Baxter to Host Fourth-Quarter 2023 Financial Results Conference Call for Investors
7.2.8 Nov 03, 2023: Cardinal Health Reports First Quarter Fiscal 2024 Results and Raises Fiscal 2024 Outlook
7.2.9 Oct 24, 2023: 3M Reports Third Quarter 2023 Results; Company Increases Full Year Adjusted Earnings and Cash Flow Expectations
7.2.10 Oct 18, 2023: Edwards Lifesciences to Host Earnings Conference Call on October 25, 2023
7.2.11 Sep 19, 2023: Baxter to Host Third-Quarter 2023 Financial Results Conference Call for Investors
7.3 Government and Public Interest
7.3.1 May 21, 2024: FDA Provides Clearance to IND Application for Type 1 Diabetes Therapy SAB-142 by SAB Biotherapeutics
7.3.2 May 07, 2024: Baxter to Present at Bank of America 2024 Health Care Conference
7.3.3 Feb 23, 2024: Edwards Lifesciences to Present at the 44th Annual TD Cowen Healthcare Conference
7.3.4 Aug 28, 2023: Edwards Lifesciences to Present at the 2023 Wells Fargo Healthcare Conference
7.4 Product News
7.4.1 Oct 05, 2023: KORU Medical Systems to Present Two Abstracts at the Immunoglobulin National Society 2023 National Conference
7.4.2 Sep 05, 2023: GE Medical Systems, Ultrasound & Primary Care Diagnostics Receives an Additional 510(k) Clearance for Vscan Air

8.1 Research Methodology
8.1.1 Coverage
8.1.2 Secondary Research
8.1.3 Primary Research
8.1.4 Market Modeling and Forecasting
8.1.5 Company Share Analysis
8.1.6 Distribution Share Analysis
8.1.7 Benchmarking
8.2 the analyst Consulting
8.3 Contact the Publisher
8.4 Disclaimer

Table 1: Infusion Systems Market, United States, Revenue ($m), USD Constant, 2018-2033
Table 2: Infusion Pump Disposables Market, United States, Revenue ($m), USD Constant, 2018-2033
Table 3: Infusion Pumps Market, United States, Revenue ($m), USD Constant, 2018-2033
Table 4: Infusion Systems Market, United States, Volume (Units), 2018-2033
Table 5: Infusion Pump Disposables Market, United States, Volume (Units), 2018-2033
Table 6: Infusion Pumps Market, United States, Volume (Units), 2018-2033
Table 7: Infusion Systems Market, United States, Average Price ($), 2018-2033
Table 8: Infusion Systems Market, United States, Distribution Share by Revenue ($m), USD Constant, 2023
Table 9: Infusion Systems Market, United States, Company Share by Revenue ($m), USD Constant, 2023
Table 10: Infusion Systems Market Pipeline Products
Table 11: ANI Pharma to Acquire Alimera Sciences for Approximately USD381 Million
Table 12: Cardinal Health Raises USD650 Million in Public Offering of 5.125% Notes Due 2029
Table 13: Cardinal Health Raises USD500 Million in Public Offering of 5.45% Notes Due 2034
Table 14: TriSalus Life Sciences' Selling Shareholders to Raise USD0.77 Million in Secondary Offering of Shares
Table 15: Trisalus Life Sciences Raises USD30 Million in Private Placement of Shares
Table 16: 3M to Enter into Co Development Agreement With HD Korea Shipbuilding & Offshore Engineering (KSOE)
Table 17: KORU Medical Enters into Co-Development Agreement with Biopharmaceutical Company
Table 18: Total Number of Primary Research Participants, Drug Delivery Devices Market, by Country

Figure 1: Infusion Systems Market, United States, Revenue ($m), USD Constant, 2018-2033
Figure 2: Infusion Pump Disposables Market, United States, Revenue ($m), USD Constant, 2018-2033
Figure 3: Infusion Pumps Market, United States, Revenue ($m), USD Constant, 2018-2033
Figure 4: Infusion Systems Market, United States, Volume (Units), 2018-2033
Figure 5: Infusion Pump Disposables Market, United States, Volume (Units), 2018-2033
Figure 6: Infusion Pumps Market, United States, Volume (Units), 2018-2033
Figure 7: Infusion Systems Market, United States, Company Share (%) 2023